Screening bone marrow samples for abnormal lymphoid populations and myelodysplasia-related features with one 10-color 14-antibody screening tube

Cytometry Part B - Clinical Cytometry

Volumn 88, Issue 4, 2015, Pages 253-260

  Rajab, Amr ^a   Porwit, Anna ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

bone marrow; flow cytometry; lymphoma; myelodysplastic syndrome

Indexed keywords

CD45 ANTIGEN; MONOCLONAL ANTIBODY; LEUKOCYTE ANTIGEN;

ANTIBODY SCREENING; ARTICLE; B LYMPHOCYTE; BONE MARROW BIOPSY; CD10+ B CELL; CD19+ B CELL; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD5+ B CELL; CD5+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN TISSUE; KARYOTYPING; LYMPHOID CELL; MAJOR CLINICAL STUDY; MYELOBLAST; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE NEOPLASM; PLASMA CELL; PLASMACYTOMA; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; BONE MARROW; BONE MARROW CELL; CYTOLOGY; IMMUNOLOGY; IMMUNOPHENOTYPING; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; PATHOLOGY; PROCEDURES; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD; B-LYMPHOCYTES; BONE MARROW; BONE MARROW CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MYELODYSPLASTIC SYNDROMES; MYELOPROLIFERATIVE DISORDERS; T-LYMPHOCYTE SUBSETS;

EID: 84932200033     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.21233     Document Type: Article

References (30)

1. Davis BH, Holden JT, Bene MC, Borowitz MJ, Braylan RC, Cornfield D, Gorczyca W, Lee R, Maiese R, Orfao A, et al., 2006 Bethesda international consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: Medical indications. Cytom B Clin Cytom 2007; 72: S5-S13.
2. Wood BL, Arroz M, Barnett D, DiGiuseppe J, Greig B, Kussick SJ, Oldaker T, Shenkin M, Stone E, Wallace P,. 2006 Bethesda international consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytom B Clin Cytom 2007; 72: S14-S22.
3. Bene MC, Nebe T, Bettelheim P, Buldini B, Bumbea H, Kern W, Lacombe F, Lemez P, Marinov I, Matutes E, et al., Immunophenotyping of acute leukemia and lymphoproliferative disorders: A consensus proposal of the European LeukemiaNet work package 10. Leukemia 2011; 25: 567-574.
4. Craig FE, Foon KA,. Flow cytometric immunophenotyping for hematologic neoplasms. Blood 2008; 111: 3941-3967.
5. Johansson U, Bloxham D, Couzens S, Jesson J, Morilla R, Erber W, Macey M,. Guidelines on the use of multicolour flow cytometry in the diagnosis of haematological neoplasms. British committee for standards in haematology. Br J Haematol 2014; 165: 455-488.
6. Ogata K, Kishikawa Y, Satoh C, Tamura H, Dan K, Hayashi A,. Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes. Blood 2006; 108: 1037-1044.
7. Della Porta MG, Picone C, Pascutto C, Malcovati L, Tamura H, Handa H, Czader M, Freeman S, Vyas P, Porwit A, et al., Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: Results of a European LeukemiaNET study. Haematologica 2012; 97: 1209-1217.
8. Della Porta MG, Picone C, Tenore A, Yokose N, Malcovati L, Cazzola M, Ogata K,. Prognostic significance of reproducible immunophenotypic markers of marrow dysplasia. Haematologica 2014; 99: e8-e10.
9. Porwit A, van de Loosdrecht AA, Bettelheim P, Brodersen LE, Burbury K, Cremers E, Della Porta MG, Ireland R, Johansson U, Matarraz S, et al., Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes-proposal from the international/European LeukemiaNet working group for flow cytometry in MDS. Leukemia 2014; 28: 1793-1798.
10. Heron M, Dovern E, Bakker-Jonges LE, Posthuma EF, Brouwer RE, Smedts F, Batstra MR,. Translating the MDS flow cytometric score into clinical practice. Cytom B Clin Cytom 2014.
11. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman J,. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. Lyon: IARC; 2008.
12. Tanqri S, Vall H, Kaplan D, Hoffman B, Purvis N, Porwit A, Hunsberger B, Shankey TV,. Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and I. Cytom B Clin Cytom 2013; 84: 291-308.
13. ICSH/ICCS Workgroup. Validation of cell-based fluorescence assays: practice guidelines from the international council for standardization of haematology and international clinical cytometry Society. Cytom B Clin Cytom 2013; 84: 281.
14. Porwit A,. Immunophenotyping of selected hematologic disorders-Focus on lymphoproliferative disorders with more than one malignant cell population. Int J Lab Hematol 2013; 35: 275-282.
15. Rajab A, Boerner S, da Cunha Santos G, Geddie W, Ko H, Porwit A,. Ten-color 14 antibody flow cytometry panel for immunophenotyping of paucicellular cytologic specimens. Cytom B Clin Cytom 2013; 84: 419.
16. Johansson U, Macey M,. Tandem dyes: Stability in cocktails and compensation considerations. Cytom B Clin Cytom 2014; 86: 164-174.
17. Davis BH, Wood B, Oldaker T, Barnett D,. Validation of cell-based fluorescence assays: Practice guidelines from the ICSH and I. Cytom B Clin Cytom 2013; 84: 282.
18. Costa ES, Arroyo ME, Pedreira CE, Garcia-Marcos MA, Tabernero MD, Almeida J, Orfao A,. A new automated flow cytometry data analysis approach for the diagnostic screening of neoplastic B-cell disorders in peripheral blood samples with absolute lymphocytosis. Leukemia 2006; 20: 1221-1230.
19. Quijano S, Lopez A, Manuel SJ, Panizo C, Deben G, Castilla C, Antonio Garcia-Vela J, Salar A, Alonso-Vence N, Gonzalez-Barca E, et al., Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: Improved sensitivity of flow cytometry. J Clin Oncol 2009; 27: 1462-1469.
20. van Dongen JJ, Lhermitte L, Bottcher S, Almeida J, van der Velden VH, Flores-Montero J, Rawstron A, Asnafi V, Lecrevisse Q, Lucio P, et al., EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia 2012; 26: 1908-1975.
21. Sancho JM, Orfao A, Quijano S, Garcia O, Panizo C, Perez-Ceballos E, Deben G, Salar A, Gonzalez-Barca E, Alonso N, et al., Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era. Eur J Haematol 2010; 85: 321-328.
22. Preijers FW, Huys E, Moshaver B,. OMIP-010: A new 10-color monoclonal antibody panel for polychromatic immunophenotyping of small hematopoietic cell samples. Cytom A 2012; 81: 453-455.
23. Carulli G, Stacchini A, Marini A, Ciriello MM, Zucca A, Cannizzo E, Aliberti S, Demurtas A, Novero D, Calcagno L, et al., Aberrant expression of CD8 in B-cell non-hodgkin lymphoma: A multicenter study of 951 bone marrow samples with lymphomatous infiltration. Am J Clin Pathol 2009; 132: 186-190.
24. Gu MJ, Ha JO,. CD56 positive diffuse large B-cell lymphoma: A case report and literature review. Int J Clin Exp Pathol 2013; 6: 3023-3025.
25. Di Bona E, Sartori R, Zambello R, Guercini N, Madeo D, Rodeghiero F,. Prognostic significance of CD56 antigen expression in acute myeloid leukemia. Haematologica 2002; 87: 250-256.
26. Malcovati L, Hellstrom-Lindberg E, Bowen D, Ades L, Cermak J, del Canizo C, Della Porta MG, Fenaux P, Gattermann N, Germing U, et al., Diagnosis and treatment of primary myelodysplastic syndromes in adults: Recommendations from the European LeukemiaNet. Blood 2013; 122: 2943-2964.
27. van de Loosdrecht AA, Ireland R, Kern W, Della Porta MG, Alhan C, Balleisen JS, Bettelheim P, Bowen DT, Burbury K, Eidenschink L, et al., Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: Position paper of an international consortium and the European LeukemiaNet working group. Leuk Lymph 2013; 54: 472-475.
28. Aalbers AM, van den Heuvel-Eibrink MM, de H V, Te Marvelde JG, de Jong AX, van der Burg M, Dworzak M, Hasle H, Locatelli F, De Moerloose B, et al., Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood. Leukemia 2013; 27: 1923-1925.
29. Westers TM, Ireland R, Kern W, Alhan C, Balleisen JS, Bettelheim P, Burbury K, Cullen M, Cutler JA, Della Porta MG, et al., Standardization of flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet working group. Leukemia 2012; 26: 1730-1741.
30. Porwit A,. Role of flow cytometry in diagnostics of myelodysplastic syndromes-Beyond the WHO 2008 classification. Semin Diagn Pathol 2011; 28: 273-282.